In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Ophthotech Corporation. Trade Record

NASDAQ:OPHT Ophthotech Corporation stock gains 19.67% Exit Nov 27, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart OPHT Nov 8, 2017, priceSeries
About Ophthotech Corporation

Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate, Fovista, an anti-platelet derived growth factor, is in Phase III clinical development for use in combination with anti-vascular endothelial growth factor drugs for the treatment of wet age-related macular degeneration (AMD). The company is also developing Zimura, an inhibitor of complement factor C5, for the treatment of dry AMD and wet AMD. Ophthotech Corporation was founded in 2007 and is headquartered in New York, New York.

Trade Information
Trade Type
LONG
ReliabilityScore™
89.52
Entry Date
Nov 8, 2017
Entry Price
2.70
Sell Date
Nov 27, 2017
Sell Price
3.23
Net Gain
19.67%
Hold Time
12 Trading Days